SUNHO BIO-B(02898) will be suspended from trading starting April 1st, pending the publication of its full-year performance for 2025.
Singhay Biotechnology-B (02898) announces that trading of the company's shares will be suspended on the Stock Exchange of Hong Kong from 9:00 am on April 1, 2026 (Wednesday) until the company publishes the announcement of its annual performance for the year 2025.
SUNHO BIO-B(02898) announcement, the company's shares will be suspended from trading on the Stock Exchange until the company publishes the annual performance for the year 2025, starting from 9 am on April 1, 2026 (Wednesday).
Related Articles
HK Stock Market Move | HEALTHYWAY INC (02587) rose by over 4% after the results were announced, with a net profit of 54.33 million yuan for the year 2025. The company's AI technology is accelerating its spillover.
Ningbo Jianan Electronics (300880.SZ) wins bid for a national power grid related tender procurement project worth 63.03 million yuan.
A-share lunch break | Not fighting anymore? Global safe haven turned into strong buying, A-shares started April with a bang! Trillions in transactions support the "hard technology" counterattack.
HK Stock Market Move | HEALTHYWAY INC (02587) rose by over 4% after the results were announced, with a net profit of 54.33 million yuan for the year 2025. The company's AI technology is accelerating its spillover.
Ningbo Jianan Electronics (300880.SZ) wins bid for a national power grid related tender procurement project worth 63.03 million yuan.
A-share lunch break | Not fighting anymore? Global safe haven turned into strong buying, A-shares started April with a bang! Trillions in transactions support the "hard technology" counterattack.
